Growing community of inventors

Nashua, NH, United States of America

Qi An

Average Co-Inventor Count = 6.80

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 64

Qi AnChristel Iffland (6 patents)Qi AnOlivier Leger (5 patents)Qi AnHoracio Gabriel Nastri (5 patents)Qi AnMark J Cartwright (4 patents)Qi AnSean D McKenna (4 patents)Qi AnGang Hao (2 patents)Qi AnVanita D Sood (2 patents)Qi AnChristine Power (1 patent)Qi AnChristina Esdar (1 patent)Qi AnBjoern Hock (1 patent)Qi AnLars Toleikis (1 patent)Qi AnPaul Bradfield (1 patent)Qi AnXinyan Zhao (1 patent)Qi AnJohannes Yeh (1 patent)Qi AnDavid Nannemann (1 patent)Qi AnRobin Lytle (1 patent)Qi AnQi An (6 patents)Christel IfflandChristel Iffland (7 patents)Olivier LegerOlivier Leger (21 patents)Horacio Gabriel NastriHoracio Gabriel Nastri (10 patents)Mark J CartwrightMark J Cartwright (23 patents)Sean D McKennaSean D McKenna (16 patents)Gang HaoGang Hao (4 patents)Vanita D SoodVanita D Sood (3 patents)Christine PowerChristine Power (23 patents)Christina EsdarChristina Esdar (22 patents)Bjoern HockBjoern Hock (15 patents)Lars ToleikisLars Toleikis (7 patents)Paul BradfieldPaul Bradfield (4 patents)Xinyan ZhaoXinyan Zhao (1 patent)Johannes YehJohannes Yeh (1 patent)David NannemannDavid Nannemann (1 patent)Robin LytleRobin Lytle (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Merck Patent Gmbh (4 from 2,945 patents)

2. Other (1 from 832,880 patents)

3. Ares Trading S.a. (1 from 135 patents)


6 patents:

1. 11884724 - Anti-PD-L1 antibodies and uses thereof

2. 11597771 - Monoclonal antibody directed to FGFR1

3. 10759856 - Anti-PD-L1 antibodies and uses thereof

4. 10487147 - Anti-PD-L1 antibodies and uses thereof

5. 9624298 - Anti-PD-L1 antibodies and uses thereof

6. 9534054 - Monoclonal antibody directed against CXCR5

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/5/2026
Loading…